FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and ribavirin
- PMID: 25449024
- DOI: 10.1053/j.gastro.2014.10.027
FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and ribavirin
Comment on
-
Building bridges and providing transparency to the hepatitis C virus drug approval process.Gastroenterology. 2014 Dec;147(6):1201-3. doi: 10.1053/j.gastro.2014.10.028. Epub 2014 Oct 25. Gastroenterology. 2014. PMID: 25449025 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
